Lv1
40 积分 2021-06-28 加入
CAR T Cells and T-Cell Therapies for Cancer
3天前
已完结
Honing CAR T cells to tackle acute myeloid leukemia
3天前
已关闭
Role of upfront autologous transplant for peripheral T-cell lymphoma patients achieving a complete remission with first-line therapy: a systematic review and meta-analysis
1个月前
已完结
Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial
1个月前
已完结
Contemporary Management of Acute Myeloid Leukemia
3个月前
已完结
Acute myeloid leukaemia
3个月前
已完结
Glofitamab plus gemcitabine and oxaliplatin (GemOx) versus rituximab-GemOx for relapsed or refractory diffuse large B-cell lymphoma (STARGLO): a global phase 3, randomised, open-label trial
3个月前
已完结
Pirtobrutinib in relapsed or refractory B-cell malignancies (BRUIN): a phase 1/2 study
3个月前
已完结
Glofitamab plus gemcitabine and oxaliplatin (GemOx) versus rituximab-GemOx for relapsed or refractory diffuse large B-cell lymphoma (STARGLO): a global phase 3, randomised, open-label trial
4个月前
已完结
Contemporary dose-escalation methods for early phase studies in the immunotherapeutics era
5个月前
已完结
皖公网安备34019202002308
